Stock Analysis of Anixa Biosciences Inc (ANIX) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ANIX
Close 2.85
Change -0.060 / 2.06 %
Volume 73975.00
Vol Change 45279.00 / 157.79 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Anixa Biosciences Inc
PE (TTM)

-8.46

Very Poor
Price / Book

3.56

Very Poor
Price / Sales

242.04

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

90914.43 K

Enterprise Value

90051.43 K

ROA (TTM)

-39.26

Very Poor
ROE (TTM)

-40.57

Very Poor
Net Margin (TTM)

-2861.20

Very Poor
Revenue

99.99 %

210000
Net Profit

27.83 %

-9811.00 K
Debt to Equity

0.0021

Excellent
Altman Z Score

12.52

Excellent
Quick Ratio

0

Poor
Cash Ratio

11.76

Excellent


Highs/Lows of Anixa Biosciences Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week3.0 5.00 % 1.54 % 3.042.8315-May-2417-May-24
Two Week2.94 3.06 % 3.42 % 3.072.8309-May-2417-May-24
One Month3.05 6.56 % 5.60 % 3.39992.8324-Apr-2417-May-24
Three Month4.05 29.63 % 5.95 % 4.12.8320-Mar-2417-May-24
Six Months2.95 3.39 % 17.48 % 5.132.7518-Jan-2422-Nov-23
One year3.43 16.91 % 27.52 % 5.132.7518-Jan-2422-Nov-23
Two year3.39 15.93 % 29.70 % 6.452.7517-Apr-2322-Nov-23
Five year4.27 33.26 % 85.46 % 6.451.3317-Apr-2327-Mar-20
Ten year8.175 65.14 % 182.41 % 8.950.600126-Jun-1515-Aug-17


Technical View of Anixa Biosciences Inc
RSI

41.45

Neutral
MACD

-0.082

Bullish
ADX

18.63

Bearish
Super Trend

3.33

Mild Bearish
Williams %R

-93.75

Mild Bearish
CCI

-146.03

Mild Bearish


EMA 5

2.91

Strong Bearish
EMA 15

2.97

Strong Bearish
EMA 50

3.19

Strong Bearish
EMA 100

3.39

Strong Bearish
SMA 100

3.67

Strong Bearish
SMA 200

3.54

Strong Bearish
SMA 5 / 20

2.93 / 3.00

Mild Bearish
SMA 15 / 50

2.96 / 3.16

Mild Bearish
SMA 50 / 200

3.16 / 3.54

Bearish




Charts of Anixa Biosciences Inc


Returns of Anixa Biosciences Inc with Peers
Period / StockANIXMISTIOBTBWAY
1 Week-5.00%2.35%-3.50%0.938%
1 Mth-6.56%-0.571%-8.00%6.53%
3 Mth-29.63%13.73%-13.21%-20.65%
6mth-3.39%-20.91%38.79%13.03%
1 Year-16.91%-56.61%-32.02%241.59%
2 Year-15.93%-69.09%-77.67%-17.23%
5 Years-33.26%-90.70%--50.56%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Anixa Biosciences Inc with Peers
Ratio / StockANIXMISTIOBTBWAY
PE-8.46-340.04-0.822-67.13
P/B3.56521.690.5732.51
ROA-39.26-59.05-62.69-2.68
ROE-40.57-153.42-69.69-3.96
Debt To Equity0.00213.000.00490.0056
Revenue210000
99.99 % 		4500.00 K
10.00 % 		0
% 		28789.00 K
5.93 %
Net Income-9811.00 K
27.83 % 		-59251.00 K
3.71 % 		-79972.00 K
11.91 % 		-8191.00 K
38.64 %


Technicals of Anixa Biosciences Inc with Peers
Technical / StockANIXMISTIOBTBWAY-
ADX18.6318.7722.6414.28
CMF-0.315-0.062-0.198-0.312
MFI35.7463.3828.7840.50
RSI41.4555.9539.3448.69
MACD Abv SignalTrueTrueFalseFalse
Price Above 50 MAFalseTrueFalseFalse-
Price Above 200 MAFalseFalseFalseTrue-


About : Anixa Biosciences Inc

Address : 3150 Almaden Expressway, San Jose, CA, United States, 95118
Tel : 408 708 9808
URL : https://www.anixa.com
Code : ANIX, ISIN : US03528H1095, Exchange : NASDAQ, Country : USA
Fiscal Year End : October
IPO date : 01_Jan_1987
Employee Count : 4

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)